Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60